Johnson & Johnson posts earnings of $1.56 a share vs. $1.54 estimate

Wall Street analysts expected pharmaceutical company Johnson& Johnson to report earnings of $1.54 per share on revenue of $17.31 billion, according to a consensus estimate. What is Johnson& Johnson stock doing now? Year to date, Johnson& Johnson has underperformed the broader S&P 500 pharmaceutical industry.